Loring Wolcott & Coolidge Fiduciary Advisors’s Atlanta Braves Holdings Series B BATRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-6
Closed -$218 558
2023
Q3
$218 Buy
+6
New +$227 ﹤0.01% 599
2017
Q4
Sell
-14
Closed 749
2017
Q3
$0 Sell
14
-341
-96% -$8.42K ﹤0.01% 789
2017
Q2
$9K Hold
355
﹤0.01% 553
2017
Q1
$8K Sell
355
-182
-34% -$3.89K ﹤0.01% 560
2016
Q4
$11K Sell
537
-31
-5% -$578 ﹤0.01% 520
2016
Q3
$10K Hold
568
﹤0.01% 541
2016
Q2
$8K Buy
+568
New +$8.47K ﹤0.01% 555

Other funds holding BATRK

Loring Wolcott & Coolidge Fiduciary Advisors's BATRK Position: Q4 2023 in Review

Loring Wolcott & Coolidge Fiduciary Advisors sold out of Atlanta Braves Holdings Series B (BATRK) in Q4 2023, closing a stake of 6 shares — an estimated $218 sold.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in BATRK in Q2 2016 and held it in 7 quarters. The position peaked at $11K in Q4 2016. 273 funds tracked by Wall St. Rank hold BATRK as of Q4 2023.

  • Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining Atlanta Braves Holdings Series B position as of Q4 2023 after selling out during the quarter.
  • Loring Wolcott & Coolidge Fiduciary Advisors sold 6 Atlanta Braves Holdings Series B shares in Q4 2023, an estimated $218.
  • Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Atlanta Braves Holdings Series B in Q2 2016 and held it in 7 quarters.
  • Loring Wolcott & Coolidge Fiduciary Advisors's Atlanta Braves Holdings Series B position peaked at $11K in Q4 2016.
  • 273 funds tracked by Wall St. Rank held Atlanta Braves Holdings Series B as of Q4 2023.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q4 2023, filed 1 Feb 2024.